Dr Reddy's Laboratories zooms to an all-time time after reporting above-estimate December quarter results
The company's consolidated profit after tax (PAT) jumped by 11 per cent, while its revenue from operations was up by seven per cent Year-on-Year (YoY).
)
Dr Reddy's Laboratories Share Price: In the first trading session on BSE after the pharma firm reported above-estimate third quarter results, Dr Reddy's Laboratories hit an all-time high of Rs 5998.00 on Wednesday (January 31, 2024).
The stock of one of the biggest pharma firms in India was trading up by 2.41 per cent, or Rs 140.80 at Rs 5986.55 at 10:18 am.
The company's consolidated profit after tax (PAT) jumped by 11 per cent, while its revenue from operations was up by seven per cent Year-on-Year (YoY).
Dr Reddy's Laboratories said in its Q3 results that one of its subsidiaries will invest Rs 650 crore in Aurigene Oncology Ltd.
The board approval for the investment will be done in one or more phases.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
01:26 PM IST
Dr Reddy's unit gets penalty of Rs 28.7 lakh from Kazakhstan authority
Dr Reddy's Labs gets Rs 27 lakh penalty from Mexican drug regulator